From our partner Irene Tarragó

The meeting of the Ordinary General Meeting of Partners of the Society Neuroserveis – Angels Inversiones (mjn-neuro) has just ended and the time has come to reflect on what was heard during it.

I am very grateful to mjn-neuro, for letting me be part of that great family since 2018 as a collaborator and since 2021 as a partner, although I already knew them before. Being a very small investor, but collaborating every month to make epilepsy visible, it seems to me that when I address you or write these entries for your blog, I am moving at home. I already consider you something of mine.

Your first device, mjn-SERAS, hooked me, made me fall in love. I have epilepsy and I am lucky to have it completely controlled with medication. But I know the reality of many people with epilepsy who, even with medication, do not control the seizures and continue to have them, causing them stress and fear of being alone or leaving the house or trying to lead a normal life. Their quality of life is very bad, because they cannot enjoy themselves. With this device, they have the peace of mind that the device will warn them of an imminent crisis and they will be able to take measures to avoid getting hurt or simply ask for help. This is very great, because your quality of life improves a lot.

Furthermore, it responds to an act of love from a father towards his daughter. A father who abandoned his professional career to dedicate himself solely and exclusively to the research and development of this device to improve the quality of life of his daughter and that of as many as possible.

Precisely, I am preparing a proposal to present to the Municipal Board of Hortaleza, requesting a Day Center for people with Alzheimer’s in our district. Your device, mjn-DREAMER, for early diagnosis is a very important contribution in the fight against Alzheimer’s, because if we are not going to cure it, we can provide treatments as soon as possible to stop the progression of the disease. Treating a brain damaged by 40% is not the same as treating it by 80%.

As for the mjn-VISOR “holter” device, a headband for performing EEG outside the hospital, I think it is sensational. Many people are greatly influenced by the mere fact of going to the hospital. Being able to do it in a Day Center, or in their usual Health Center is very good for them. Or I wonder if the possibility could be considered that a qualified person could go to your home to do it.

So congratulations for your work, for your research in these fields to try to improve people’s quality of life. I prefer not to see it as a business, but as something necessary and fair, as a small contribution on my part to society so that other people have a better life. Always through you, of course, but I love being part of it.

With your permission I have used your images.

Irene Tarragó Pascau

Leave a Reply

Open chat
1
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.